DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 210 filers reported holding DEPOMED INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $263,000 | +1.2% | 39,429 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $260,000 | -18.0% | 39,429 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $317,000 | +39.0% | 39,429 | 0.0% | 0.00% | +100.0% |
Q3 2017 | $228,000 | -33.9% | 39,429 | +22.8% | 0.00% | -66.7% |
Q2 2017 | $345,000 | -36.5% | 32,100 | -25.9% | 0.00% | -40.0% |
Q1 2017 | $543,000 | -30.4% | 43,300 | 0.0% | 0.01% | -37.5% |
Q4 2016 | $780,000 | -27.9% | 43,300 | 0.0% | 0.01% | -27.3% |
Q3 2016 | $1,082,000 | +27.3% | 43,300 | 0.0% | 0.01% | +22.2% |
Q2 2016 | $850,000 | +46.8% | 43,300 | +4.1% | 0.01% | +50.0% |
Q1 2016 | $579,000 | -23.2% | 41,600 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $754,000 | -39.8% | 41,600 | -37.3% | 0.01% | -45.5% |
Q3 2015 | $1,252,000 | -37.0% | 66,400 | -28.3% | 0.01% | -21.4% |
Q2 2015 | $1,987,000 | -21.2% | 92,600 | -17.7% | 0.01% | -26.3% |
Q1 2015 | $2,521,000 | +41.6% | 112,500 | +1.8% | 0.02% | +58.3% |
Q4 2014 | $1,780,000 | +7.1% | 110,500 | +1.0% | 0.01% | +9.1% |
Q3 2014 | $1,662,000 | – | 109,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |